Trilogy Capital’s First Trust Financials AlphaDEX Fund FXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,588
Closed -$242K 313
2023
Q4
$242K Sell
5,588
-420
-7% -$16.4K 0.02% 233
2023
Q3
$227K Buy
+6,008
New +$237K 0.02% 244

Other funds holding FXO

Trilogy Capital's FXO Position: Q1 2024 in Review

Trilogy Capital sold out of First Trust Financials AlphaDEX Fund (FXO) in Q1 2024, closing a stake of 5,588 shares — an estimated $242K sold.

Trilogy Capital first reported a position in FXO in Q3 2023 and held it in 2 quarters. The position peaked at $242K in Q4 2023. 185 funds tracked by Wall St. Rank hold FXO as of Q1 2024.

  • Trilogy Capital reported no remaining First Trust Financials AlphaDEX Fund position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 5,588 First Trust Financials AlphaDEX Fund shares in Q1 2024, an estimated $242K.
  • Trilogy Capital first reported a position in First Trust Financials AlphaDEX Fund in Q3 2023 and held it in 2 quarters.
  • Trilogy Capital's First Trust Financials AlphaDEX Fund position peaked at $242K in Q4 2023.
  • 185 funds tracked by Wall St. Rank held First Trust Financials AlphaDEX Fund as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.